The Food and Drug Administration (FDA) has reported the discovery of a new batch of bogus Avastin, in addition to the incident published March 14th on BlueNC. This product was labeled as Altuzan, the brand name of the drug used in Turkey. It is used with chemotherapy in treating colon, lung and other kinds of cancer. This shipment was traced through at least six different countries before arriving in the United States. The only location that authorities cite for using this drug is a clinic near St. Louis, MO.
The FDA and manufacturers tend to minimize publicity on these events, but for different reasons. The FDA does not want the public or Congress to get the impression that they are not doing their job, while the company is concerned about any damage to their brand name. The motivation for making and distributing these items is the exceptionally high and rising price of some drugs that has proven to be a powerful magnet.